Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 141,368 shares at $6.64 ($941K) on 2024-06-04, disclosed to the SEC on 2024-06-05.
Scheduled sale ($941k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.47 | 19,864 | $129K | 13.7% |
| 2 | $6.47 | 19,864 | $129K | 13.7% |
| 3 | $6.64 | 40,595 | $270K | 28.7% |
| 4 | $6.64 | 40,595 | $270K | 28.7% |
| 5 | $7.06 | 20,450 | $144K | 15.4% |
| Total | $6.65 avg | 141,368 |
| $941K |
| 100% |
| Filing → |
| RLAY | SELL | 2026-07-02 | $955K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |